Evidence map›Paper›PMID 36380827›Full record

ArticleThe journal of extra-corporeal technology2022

Early Initiation of Venovenous Extracorporeal Membrane Oxygenation for Critically Ill COVID-19 Patients.

Takeshi Goto, Shinya Yaguchi, Junko Ogasawara, Naotaka Kato, Jin Irie, Hiroaki Ichikawa, Yuki Nishiya, Yoshiya Ishizawa, Osamu Nomura, Hiroyuki Hanada

Open access · greenAbstract readCase Reports
In one paragraph

Article in The journal of extra-corporeal technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Takeshi GotoDepartment of Clinical Engineering, Hirosaki University School of Medicine and Hospital, Aomori, Japan; and the.
Shinya YaguchiDepartment of Emergency and Disaster Medicine, Hirosaki University, Aomori, Japan.
Junko OgasawaraDepartment of Clinical Engineering, Hirosaki University School of Medicine and Hospital, Aomori, Japan; and the.
Naotaka KatoDepartment of Clinical Engineering, Hirosaki University School of Medicine and Hospital, Aomori, Japan; and the.
Jin IrieDepartment of Emergency and Disaster Medicine, Hirosaki University, Aomori, Japan.
Hiroaki IchikawaDepartment of Emergency and Disaster Medicine, Hirosaki University, Aomori, Japan.
Yuki NishiyaDepartment of Emergency and Disaster Medicine, Hirosaki University, Aomori, Japan.
Yoshiya IshizawaDepartment of Emergency and Disaster Medicine, Hirosaki University, Aomori, Japan.
Osamu NomuraDepartment of Emergency and Disaster Medicine, Hirosaki University, Aomori, Japan.
Hiroyuki HanadaDepartment of Emergency and Disaster Medicine, Hirosaki University, Aomori, Japan.
Hirosaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The optimal timing for initiating extracorporeal membrane oxygenation (ECMO) after starting mechanical ventilation has yet to be clarified. We report herein the cases of two patients with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) who were successfully managed with an early ECMO induction strategy. Case 1 involved a 64-year-old man admitted in respiratory distress with polymerase chain reaction-confirmed COVID-19. On day 5 at hospital, he was intubated, but oxygenation remained unimproved despite mechanical ventilation treatment with high positive end-expiratory pressure (PEEP) (PaO

Indexed as

COVID-19Extracorporeal Membrane OxygenationRespiratory Distress SyndromeCritical IllnessHumansMaleMiddle AgedRespiration, Artificialacute respiratory distress syndrome.COVID-19early initiationextracorporeal membrane oxygenationindication

Identifiers

PMID36380827
PMCPMC9639695
OpenAlexW4309362940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.